Follow us:

MedWatch Safety Alerts

MedWatch Safety Alert RSS Feed

FDA MedWatch Safety Alerts

Skin and nail fungal infections in otherwise healthy persons are not life-threatening, and so the risks associated with oral ketoconazole outweigh the benefits. Posted 05/19/2016
Posted: May 19, 2016, 4:00 am
Administration of a drug product intended to be sterile that is compromised may result in serious and potentially life-threatening infections or death.
Posted: May 18, 2016, 5:00 pm
FDA is currently investigating this new safety issue. Patients should not stop or change their diabetes medicines.
Posted: May 18, 2016, 4:56 pm
Sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
Posted: May 13, 2016, 2:50 pm
FDA urges health care professionals to purchase drug products only from legitimate suppliers.
Posted: May 13, 2016, 2:40 pm
Serious side effects associated with fluoroquinolones generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections who have other treatment options.
Posted: May 12, 2016, 6:50 pm
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) can result in injury to organs including the liver, kidneys, lungs, heart, or pancreas, and can lead to death.
Posted: May 10, 2016, 4:01 pm
The presence of glass particulate matter could block drug administration, delaying therapy, and may also result in local inflammation, mechanical disruption of tissue, or cause an immune response.
Posted: May 9, 2016, 12:30 pm
The presence of air in dialysis fluid may lead to improper blood filtration, causing serious adverse health consequences, including death.
Posted: May 4, 2016, 2:30 pm
Degradation could lead to loss of device function, separation of a device segment leading to medical intervention, or complications resulting from a separated segment.
Posted: May 4, 2016, 1:10 pm
Compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of aripiprazole, and may result in harm to the patient and others if not recognized.
Posted: May 3, 2016, 4:30 pm
During transition from the name Brintellix to Trintellix, prescribers can reduce the risk of name confusion by including the generic name of the medication they are ordering, in addition to the brand name and indication for use.
Posted: May 2, 2016, 7:10 pm
Undeclared sibutramine or sildenafil poses a threat to consumers.
Posted: May 2, 2016, 2:25 pm
Administration of a solution containing glass particulate matter may result in inflammation and injury, or cause blockage of vasculature around the eye or emboli in the vasculature of eye nerves.
Posted: April 26, 2016, 9:30 pm
Danish study shows possible increased risk of miscarriage. FDA advises cautious prescribing of oral fluconazole in pregnancy, until more is understood about this study.
Posted: April 26, 2016, 1:00 pm
Thermal damage may cause fire, resulting in smoke inhalation and minor burns.
Posted: April 20, 2016, 8:30 pm
Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death.
Posted: April 16, 2016, 3:42 pm
Drug Safety Labeling Changes includes 35 products with revisions to Prescribing Information. Posted 04/15/2016
Posted: April 15, 2016, 12:22 pm
Administration may result in localized swelling, redness, pain at the site of administration or veins, allergic reactions to the foreign particle, microembolic effects as well as possible fetal harm.
Posted: April 14, 2016, 3:00 pm
Inaccurate results may lead to improper patient treatment for HSV or GAS and may cause serious adverse health consequences, including death.
Posted: April 14, 2016, 11:30 am